Sunshield Chemicals (SUNSHIEL)₹918.40−2.11%Specialty Chemicals
In the Jun 2026 quarter (standalone), Sunshield Chemicals reported sales of ₹127 Cr, up 11.3% from Jun 2025, and net profit of ₹13.02 Cr, up 85.7% year on year. For the year to Mar 2026, sales were ₹442 Cr and net profit ₹30.06 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66.13 | 65.18 | 86.17 | 78.12 | 93.27 | 85.16 | 110 | 114 | 122 | 95.27 | 110 | 127 |
| Expenses | 56.88 | 54.92 | 72.83 | 69.92 | 84.81 | 77.91 | 98.83 | 101 | 108 | 85.87 | 92.87 | 107 |
| Operating Profit | 8.98 | 10.97 | 11.98 | 7.98 | 7.99 | 6.99 | 11.98 | 12.99 | 13.99 | 8.99 | 15.96 | 19.96 |
| OPM % | 13.9% | 15.9% | 13.9% | 10.0% | 7.9% | 7.9% | 9.9% | 10.9% | 11.0% | 9.9% | 14.9% | 15.9% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 1.01 | 0.00 | 1.01 |
| Interest | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 1.01 | 0.00 | 0.00 |
| Depreciation | 2.01 | 2.01 | 2.01 | 2.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Profit before tax | 5.01 | 7.02 | 9.02 | 4.01 | 4.01 | 2.01 | 8.01 | 9.01 | 10.01 | 7.01 | 14.03 | 18.02 |
| Tax % | 29.0% | 30.1% | 30.0% | −6.0% | 26.0% | 31.0% | 24.0% | 26.0% | 25.0% | 26.0% | 24.0% | 25.0% |
| Net Profit | 4.01 | 5.01 | 6.01 | 4.01 | 3.01 | 2.01 | 6.01 | 7.01 | 7.01 | 5.01 | 11.02 | 13.02 |
| EPS (Rs) | 4.42 | 5.84 | 6.82 | 4.57 | 3.63 | 1.86 | 6.54 | 7.77 | 8.24 | 5.57 | 12.16 | 15.39 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 166 | 183 | 191 | 181 | 199 | 244 | 245 | 284 | 367 | 442 | 455 |
| Expenses | 140 | 157 | 168 | 173 | 164 | 169 | 213 | 214 | 242 | 331 | 388 | 393 |
| Operating Profit | 9.98 | 8.99 | 15.97 | 15.98 | 16.98 | 29.93 | 30.93 | 30.94 | 39.93 | 33.93 | 51.87 | 58.90 |
| OPM % | 7.0% | 5.0% | 7.9% | 8.9% | 8.9% | 14.9% | 12.9% | 12.9% | 13.9% | 8.9% | 11.9% | 13.0% |
| Other Income | 3.01 | −2.01 | 2.01 | 1.01 | 0.00 | 0.00 | 19.04 | 2.01 | 1.01 | 3.01 | 3.01 | 2.02 |
| Interest | 11.04 | 9.03 | 10.04 | 11.04 | 10.05 | 7.02 | 5.02 | 7.02 | 8.03 | 9.03 | 5.02 | 3.02 |
| Depreciation | 5.01 | 6.01 | 6.01 | 6.01 | 6.02 | 6.02 | 6.01 | 6.01 | 7.01 | 10.02 | 11.02 | 12.04 |
| Profit before tax | −3.01 | −8.02 | 2.01 | 0.00 | 1.01 | 17.04 | 39.04 | 19.05 | 27.05 | 18.03 | 40.09 | 49.07 |
| Tax % | −75.0% | −15.9% | 20.0% | 0.0% | 46.0% | 15.1% | 30.1% | 28.1% | 30.0% | 19.0% | 25.0% | — |
| Exceptional items | 0.00 | −1.99 | 0.00 | −1.99 | −0.99 | 0.00 | 11.96 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | −1.01 | −7.02 | 1.01 | 0.00 | 1.01 | 14.04 | 27.04 | 14.03 | 19.04 | 15.03 | 30.06 | 36.06 |
| EPS (Rs) | −0.98 | −7.59 | 1.37 | 0.26 | 0.74 | 16.15 | 31.33 | 15.57 | 21.47 | 16.61 | 33.77 | 41.36 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 5.0% | 11.1% | 9.1% | 13.1% | 9.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.03 | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 | 7.03 | 7.03 | 7.02 | 7.03 | 7.02 | 9.03 |
| Reserves | 10.01 | 9.02 | 2.01 | 4.01 | 4.01 | 4.01 | 19.03 | 46.01 | 59.01 | 74.98 | 88.01 | 243 |
| Borrowings | 74.83 | 101 | 99.85 | 110 | 106 | 109 | 87.82 | 78.78 | 76.79 | 84.81 | 99.70 | 0.00 |
| Other Liabilities | 39.19 | 33.16 | 31.15 | 36.18 | 31.15 | 26.13 | 24.11 | 41.15 | 34.15 | 61.21 | 109 | 52.99 |
| Total Liabilities | 131 | 151 | 141 | 157 | 148 | 147 | 138 | 173 | 177 | 229 | 304 | 305 |
| Fixed Assets | 31.12 | 79.31 | 74.24 | 71.25 | 69.23 | 71.19 | 66.18 | 71.23 | 79.23 | 75.21 | 129 | 157 |
| CWIP | 48.12 | 2.01 | 3.01 | 3.01 | 3.01 | 0.00 | 1.01 | 7.02 | 1.01 | 45.12 | 35.13 | 6.02 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 52.82 | 69.78 | 63.78 | 82.80 | 75.79 | 75.83 | 70.80 | 94.72 | 96.73 | 109 | 141 | 142 |
| Inventories | 19.97 | 27.97 | 21.96 | 30.94 | 27.96 | 28.95 | 25.97 | 28.94 | 35.97 | 42.95 | 56.91 | 51.90 |
| Trade receivables | 12.03 | 26.05 | 27.04 | 30.06 | 27.05 | 28.05 | 29.04 | 41.05 | 40.04 | 48.11 | 64.11 | 71.06 |
| Cash & equivalents | 0.00 | 2.01 | 1.01 | 3.01 | 2.01 | 1.01 | 4.01 | 6.01 | 2.01 | 1.01 | 4.01 | 14.04 |
| Total Assets | 131 | 151 | 141 | 157 | 148 | 147 | 138 | 173 | 177 | 229 | 304 | 305 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 12.99 | 0.99 | 11.98 | 1.99 | 14.98 | 18.98 | 34.93 | 32.96 | 13.97 | 41.91 | 47.89 | 9.98 |
| Cash from investing activity | −31.05 | −17.02 | −3.01 | −4.01 | −2.01 | −7.01 | −4.01 | −17.03 | −9.01 | −40.02 | −50.06 | −20.01 |
| Cash from financing activity | 15.03 | 18.04 | −8.03 | 3.01 | −30.10 | −24.08 | −7.02 | −9.03 | −11.03 | −11.04 | 2.01 | 34.08 |
| Net cash flow | −3.01 | 2.01 | 1.01 | 1.01 | −18.04 | −11.03 | 23.05 | 7.02 | −5.02 | −9.02 | −1.01 | 23.05 |
| Capex | 30.64 | 22.58 | 3.38 | 3.92 | 2.09 | 6.74 | 3.83 | 16.33 | 8.22 | 41.43 | 49.82 | 20.09 |
| Free cash flow | −17.99 | −22.01 | 7.99 | −1.99 | 11.99 | 12.99 | 31.99 | 16.99 | 5.99 | 0.99 | −1.99 | −11.01 |
| CFO / OP % | 645.1% | 8.0% | 128.1% | 14.1% | 90.0% | 114.0% | 125.1% | 131.0% | 57.0% | 115.0% | 156.1% | 33.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 36 | 62 | 60 | 59 | 51 | 57 | 53 | 62 | 60 | 62 | 64 | 59 |
| Inventory days | 86 | 100 | 76 | 91 | 81 | 92 | 79 | 66 | 83 | 84 | 79 | 59 |
| Days payable | 70 | 91 | 71 | 70 | 60 | 72 | 63 | 74 | 54 | 79 | 83 | 42 |
| Cash conversion cycle | 51 | 71 | 64 | 79 | 71 | 76 | 68 | 52 | 88 | 66 | 59 | 75 |
| Working capital days | −68 | −20 | −57 | −52 | −91 | −27 | 3 | 8 | 42 | −20 | −45 | 71 |
| ROCE % | −1.0% | 7.0% | 3.0% | 10.0% | 11.0% | 10.0% | 20.0% | 21.0% | 19.0% | 22.0% | 15.0% | 20.0% |
For the Jun 2026 quarter, Sunshield Chemicals reported sales of ₹127 Cr, up 11.3% year on year and net profit of ₹13.02 Cr, up 85.7% year on year. The operating margin was 15.9%.
Sunshield Chemicals' sales for the year to Mar 2026 were ₹442 Cr; over the last twelve months they were ₹455 Cr.
Net profit for the year to Mar 2026 was ₹30.06 Cr, and ₹36.06 Cr over the last twelve months. Earnings per share over the same trailing period were ₹41.36.
Sunshield Chemicals reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹14.04 Cr.
Cash from operations was ₹9.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹11.01 Cr.